|
Volumn 12, Issue 3, 2016, Pages 213-215
|
Toward a consensus recommendation for defining the asymptomatic-preclinical phases of putative Alzheimer's disease?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMYLOID BETA PROTEIN;
BIOLOGICAL MARKER;
CHOLESTEROL;
ALZHEIMER DISEASE;
AMYLOID PLAQUE;
ASYMPTOMATIC DISEASE;
COGNITIVE DEFECT;
CORONARY ARTERY;
DEMENTIA;
DIAGNOSTIC ACCURACY;
DISEASE MARKER;
EARLY DIAGNOSIS;
EDITORIAL;
HUMAN;
LONGITUDINAL STUDY;
MEMORY DISORDER;
NERVE DEGENERATION;
PATHOLOGY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROGNOSIS;
CONSENSUS;
ALZHEIMER DISEASE;
CONSENSUS;
HUMANS;
|
EID: 84962309608
PISSN: 15525260
EISSN: 15525279
Source Type: Journal
DOI: 10.1016/j.jalz.2016.02.003 Document Type: Editorial |
Times cited : (5)
|
References (3)
|